Sources | Names Used |
---|---|
CTRPv2 | docetaxel:tanespimycin (2:1 mol/mol) |
PharmacoGx | docetaxel:tanespimycin (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RFWD2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | CNOT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | FAM72B | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
mRNA | S100PBP | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | LGALS3 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
mRNA | SPOUT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | FEM1A | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
mRNA | NUP43 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
mRNA | KRT8 | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
mRNA | ILF2 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |